Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 38.2%

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large decrease in short interest in March. As of March 13th, there was short interest totaling 3,423 shares, a decrease of 38.2% from the February 26th total of 5,537 shares. Based on an average daily volume of 1,474 shares, the days-to-cover ratio is currently 2.3 days.

XOMA Stock Performance

NASDAQ XOMAO opened at $25.52 on Friday. XOMA has a one year low of $23.32 and a one year high of $25.76. The company’s 50 day moving average price is $25.39 and its 200 day moving average price is $25.42.

XOMA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Thursday, April 2nd will be paid a $0.5234 dividend. This represents a $2.09 dividend on an annualized basis and a dividend yield of 8.2%. The ex-dividend date of this dividend is Thursday, April 2nd.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.